| Eric Michael Sherman, MD | |
|
2501 Capehart Rd, Offutt Afb, NE 68113-1043 | |
| (402) 294-8581 | |
| Not Available |
| Full Name | Eric Michael Sherman |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 2501 Capehart Rd, Offutt Afb, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831119502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 0101235985 (Virginia) | Secondary |
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 2021-01567 (North Carolina) | Primary |
| Entity Name | Father Flanagans Boys Home |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295821825 PECOS PAC ID: 9638165400 Enrollment ID: O20040426000622 |
News Archive
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.
University of Cincinnati (UC) epidemiologists say it's environmental tobacco smoke-not the suspected visible mold-that drastically increases an infant's risk for developing allergic rhinitis by age 1.
The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers.
› Verified 9 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053350454 PECOS PAC ID: 7416865845 Enrollment ID: O20240105002109 |
News Archive
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.
University of Cincinnati (UC) epidemiologists say it's environmental tobacco smoke-not the suspected visible mold-that drastically increases an infant's risk for developing allergic rhinitis by age 1.
The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Michael Sherman, MD 2501 Capehart Rd, Offutt Afb, NE 68113-1043 Ph: (402) 294-7311 | Eric Michael Sherman, MD 2501 Capehart Rd, Offutt Afb, NE 68113-1043 Ph: (402) 294-8581 |
News Archive
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.
University of Cincinnati (UC) epidemiologists say it's environmental tobacco smoke-not the suspected visible mold-that drastically increases an infant's risk for developing allergic rhinitis by age 1.
The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers.
› Verified 9 days ago
Dr. Lee David Williames, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273 | |
Dr. Marc Nicholas Boggy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-8581 | |
Dr. William Ryan Toth, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 400-294-6077 | |
Mariah Davis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-6077 | |
Dr. Shirley Lynn Miller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Mdg, 2501 Capehart Rd, Offutt Afb, NE 68112 Phone: 402-294-2448 | |
Dr. Raegan Leigh Austin, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273 |